Navigation Links
GUMC researchers find gene function 'lost' in melanoma and glioblastoma
Date:12/14/2008

PTPRD produces a receptor protein tyrosine phosphatase that bisects the outer membrane of a cell. The part that protrudes outside the cell body is thought to be involved in helping cells stick to each other to form a tissue as well as in cell-to-cell communication. The part that juts into the cell is an enzyme that removes phosphates from other proteins in other words, it changes the activity of proteins either by activating or deactivating them, Waldman says.

"In the absence of PTPRD, there are as yet unknown proteins floating around inside the cell with more phosphate residues than they should have, and it is a well known fact that the presence of these residues activates cellular growth pathways," he says. But it is not yet known which specific proteins PTPRD regulates, Waldman says.

Deletions of PTPRD in human cancer cells were first discovered in 2005, and since then, deletions or mutations of the gene have been discovered in several cancer types, including those of the colon and lung.

In this study, Waldman and his research team, which includes investigators from the National Cancer Institute, the University of Iowa and Duke University, used a laboratory technique known as copy number analysis to look for PTPRD in melanoma cell lines and in samples of human glioblastoma multiforme, the deadliest of brain cancers.

This technique uses a gene microarray that contains millions of probes that can stick to different regions of the human genome. The researchers purified DNA from tumors and then used the microarray chip to quantify genomic copy number. They found that PTPRD was deleted or mutated in 12 percent of melanoma tumors and in 14 percent of glioblastoma tumors examined. "That makes PTPRD one of the most commonly mutated genes discovered yet in melanoma," Waldman says.

"Before this study, no single tyrosine phosphatase was thought to play a generally important role as a tumor suppressor gene n multiple tumor types
'/>"/>

Contact: Karen Mallet
km463@georgetown.edu
414-312-7085
Georgetown University Medical Center
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Researchers identify proteins involved in new neurodegenerative syndrome
2. Texas researchers and educators head for Antarctica
3. MGH researchers describe new way to identify, evolve novel enzymes
4. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
5. U of MN researchers discover noninvasive diagnostic tool for brain diseases
6. U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases
7. Researchers discover new strategies for antibiotic resistance
8. Researchers find new taste in fruit flies: carbonated water
9. Binghamton University researchers investigate evolving malaria resistance
10. UIC researchers find promising new targets for antibiotics
11. Researchers develop simple method to create natural drug products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... major discovery is challenging accepted thinking about amyloids the ... Parkinson,s and may open up a potential new area ... rope-like structures made up of proteins sometimes known as fibres ... during their formation which can damage cells and cause disease. ...
(Date:12/3/2009)... animal species can be likened to emptying a museum of ... into the trash, or replacing every local cuisine with McDonald,s ... may not just make the world boring. New research now ... catching some nasty disease. , "Habitat destruction and biodiversity loss,"driven ...
(Date:12/3/2009)... scientists believe that staph infections are caused by many bacterial ... process is called quorum sensing because many bacteria must be ... research group has determined that the very first stage of ... virulent form, occurs in a single cell and that this ...
Breaking Biology News(10 mins):New therapy targets for amyloid disease 2Species down, disease up 2Species down, disease up 3Species down, disease up 4Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3The Scientist Names Photometrics 26apos 3B Evolve EMCCD Camera One of the 26amp 3B 238220 3BTop 10 Innovations 26amp 3B 238221 3B of 2009 15037 1The Scientist Names Photometrics 26apos 3B Evolve EMCCD Camera One of the 26amp 3B 238220 3BTop 10 Innovations 26amp 3B 238221 3B of 2009 15037 2The Scientist Names Photometrics 26apos 3B Evolve EMCCD Camera One of the 26amp 3B 238220 3BTop 10 Innovations 26amp 3B 238221 3B of 2009 15037 3Simcere Pharmaceutical Group Announces Jiangsu Yanshens Voluntary Suspension of Production 6666 1Simcere Pharmaceutical Group Announces Jiangsu Yanshens Voluntary Suspension of Production 6666 2Simcere Pharmaceutical Group Announces Jiangsu Yanshens Voluntary Suspension of Production 6666 3Online Compression Garments Retailer Introduces 3D Animation of Surgical Procedures 62418 1Online Compression Garments Retailer Introduces 3D Animation of Surgical Procedures 62418 2
... the way for improved study of hepatitis C virus ... replication of patient-isolated virus in nontransformed hepatocytes, instead of ... related report by Lázaro et al, "Hepatitis C virus ... appears in the February issue of The American Journal ...
... A study published today in the Journal of ... cases of Clostridium difficile infection (CDI)---one of the ... be reduced in hospital wards if doctors prescribe ... Researchers at the Royal Free Hospital in London, ...
... M.D., has identified a protein known as Lipocalin-2 ... inflammatory response during heart transplants. One of the ... damage done to the transplanted heart during and ... (IR). In particular, inflammatory cells infiltrate the donated ...
Other Biology News:New culture method for hepatitis C virus uses primary hepatocytes and patient serum 2Reminding doctors which antibiotics to prescribe cuts C. difficile infection rates 2Reminding doctors which antibiotics to prescribe cuts C. difficile infection rates 3Reminding doctors which antibiotics to prescribe cuts C. difficile infection rates 4
(Date:12/2/2009)... medical research executives, scientists, policy makers, and funders today ... strategies at the inaugural Partnering for Cures ... of the Milken Institute, convened Partnering for Cures ... scientific discovery into an accessible therapy. This effort ...
(Date:12/2/2009)... - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; ... its previously announced unit offering, the underwriters have exercised ... 637,500 units. Each unit is comprised of one common ... and was sold at a price of US$3.00 per ...
(Date:12/2/2009)... an event bringing together the leaders in technology ... and MEMS, announced the December 11th deadline for ... its 14th year, TechConnect World, in association with ... the Clean Technology and Sustainable Industries Organization (CTSI), ...
(Date:12/2/2009)... /PRNewswire-Asia-FirstCall/ -- Emerald Dairy, Inc.,("Emerald Dairy" or the "Company") ... infant and children,s formula, milk powder and,soybean products in ... the Spring issue of US Food & Drink Executive, ... in the food and beverage industry. , ...
Breaking Biology Technology:Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2
... COLUMBUS, Ohio, June 25 Battelle is,strengthening ... medical device, and government clients, and,Kevin Xie ... President of Biomarker,Services., Battelle offers a ... and validation services to help our clients,better ...
... MATK ) announced today that life,sDHA(TM), its ... brain and eye development, is now,available to Eastern ... Walmark. Featuring 200 mg per serving of life,sDHA,Pregnium ... Republic, Slovakia,and Romania., "There is a strong ...
... N.Y., June 25 Lixte,Biotechnology Holdings (OTC Bulletin ... Neurological Disorders and Stroke (NINDS), National,Institutes of Health ... Research and Development Agreement (CRADA) to develop,drugs for ... in March,2006 was extended through September 2009., ...
Other Biology Technology:Battelle Selects Xie to Develop Biomarker Services 2Eastern European Supplement Leader Walmark Launches Prenatal Product Featuring Martek's life'sDHA(TM) 2Eastern European Supplement Leader Walmark Launches Prenatal Product Featuring Martek's life'sDHA(TM) 3Lixte Biotechnology Holdings Announces Extension of Its Cooperative Research and Development Agreement With The National Institute of Neurological Disorders and Stroke, National Institutes of Health, for Development of Anti-Brain Cancer Drugs 2Lixte Biotechnology Holdings Announces Extension of Its Cooperative Research and Development Agreement With The National Institute of Neurological Disorders and Stroke, National Institutes of Health, for Development of Anti-Brain Cancer Drugs 3
... as a Voltage Clamp, as a Current Clamp ... research applications. Performance in any one mode is ... • This amazing instrument is made ... of Digital Signal Processing (DSP) integrated circuit chips. ...
... Agilent Technologies introduces an enhanced ... ICP-MS for Windows 2000 and ... From September 2003, all new ... controlled by the new ChemStation ...
... microRNA expression profiling and built on ... on-chip synthesis platform. These microarrays are ... microRNA Expression Profiling Service. ... microRNA Microarray contains all known soil ...
... critical to the maintenance of appropriate ... as important and diverse as those ... and stress response, antigen presentation, modulation ... channels, cell cycle regulation, transcription, and ...
Biology Products: